Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Hazel Y. Stevens"'
Autor:
Angela S. P. Lin, David S. Reece, Tanushree Thote, Sanjay Sridaran, Hazel Y. Stevens, Nick J. Willett, Robert E. Guldberg
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
Background: Micronized dehydrated human amnion/chorion membrane (mdHACM) has reduced short term post-traumatic osteoarthritis (PTOA) progression in rats when delivered 24 h after medial meniscal transection (MMT) and is being investigated for clinica
Externí odkaz:
https://doaj.org/article/68fa819005114570b22b49814442e2c5
Autor:
Annie C. Bowles-Welch, Angela C. Jimenez, Hazel Y. Stevens, David A. Frey Rubio, Linda E. Kippner, Carolyn Yeago, Krishnendu Roy
Publikováno v:
Bone Reports, Vol 18, Iss , Pp 101656- (2023)
Bone is a complex tissue capable of natural repair to injury, however, the healing process is often impaired by the untoward effects of trauma, defects, and disease. Thus, therapeutic modalities, including the use of cells involved in the body's natu
Externí odkaz:
https://doaj.org/article/f9a8f6c1ab4e4176b2ba850e5238c3c2
Autor:
Camila Medrano-Trochez, Paramita Chatterjee, Pallab Pradhan, Hazel Y. Stevens, Molly E. Ogle, Edward A. Botchwey, Joanne Kurtzberg, Carolyn Yeago, Greg Gibson, Krishnendu Roy
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2021)
Abstract Background Human Mesenchymal stromal cells (hMSCs) from various tissue sources are widely investigated in clinical trials. These MSCs are often administered to patients immediately after thawing the cryopreserved product (out-of-thaw), yet l
Externí odkaz:
https://doaj.org/article/6fea1886cd2e42f6a0a90995bb79307f
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Mesenchymal stromal cells (MSCs) have been widely investigated for regenerative medicine applications, from treating various inflammatory diseases as a cell therapy to generating engineered tissue constructs. Numerous studies have evaluated the poten
Externí odkaz:
https://doaj.org/article/67bc1f101a224a8ea5f150efaed3566c
Autor:
Giuliana E Salazar-Noratto, Catriana C Nations, Hazel Y Stevens, Maojia Xu, Sean Gaynard, Claire Dooley, Nica de Nijs, Katya McDonagh, Sanbing Shen, S Clifton Willimon, Frank Barry, Robert E Guldberg
Publikováno v:
Stem Cells Translational Medicine. 12:293-306
Juvenile osteochondritis dissecans (JOCD) is a pediatric disease, which begins with an osteonecrotic lesion in the secondary ossification center which, over time, results in the separation of the necrotic fragment from the parent bone. JOCD predispos
Autor:
Paramita Chatterjee, Joanne Kurtzberg, Krishnendu Roy, Hazel Y. Stevens, Molly E Ogle, Carolyn Yeago, Edward A. Botchwey, Pallab Pradhan, Camila Medrano-Trochez, Greg Gibson
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2021)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background Human Mesenchymal stromal cells (hMSCs) from various tissue sources are widely investigated in clinical trials. These MSCs are often administered to patients immediately after thawing the cryopreserved product (out-of-thaw), yet little is
Publikováno v:
Osteoarthritis and Cartilage. 27:294-303
Summary Objective To characterize local disease progression of the medial meniscus transection (MMT) model of post-traumatic osteoarthritis (OA) at the molecular level, in order to establish a baseline for therapeutic testing at the preclinical stage
Autor:
Lohitash Karumbaiah, Hazel Y. Stevens, Erin T. Jordan, Meghan T. Logun, Robert E. Guldberg, Albert Cheng, Boao Xia, Seth H. Andrews, Robin L. Webb, Steven L. Stice
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 8, Iss 6, Pp 575-585 (2019)
Stem Cells Translational Medicine, Vol 8, Iss 6, Pp 575-585 (2019)
Bone morphogenetic protein 2 (BMP-2)-loaded collagen sponges remain the clinical standard for treatment of large bone defects when there is insufficient autograft, despite associated complications. Recent efforts to negate comorbidities have included
Autor:
Ye Li, Camila Medrano-Trochez, Greg Gibson, Chad M. Glen, Theresa Kontanchek, Angela C. Jimenez, Wen J. Seeto, Paramita Chatterjee, Joanne Kurtzberg, Pallab Pradhan, Carolyn Yeago, Linda E. Kippner, Krishnendu Roy, Hazel Y. Stevens
Mesenchymal stromal cells (MSCs) are currently being tested in numerous clinical trials as potential cell therapies for the treatment of various diseases and due to their potential immunomodulatory, pro-angiogenic, and regenerative properties. Howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5e2ab4d19b489863ea551a68fc1b1b0
https://doi.org/10.1101/2020.09.12.294850
https://doi.org/10.1101/2020.09.12.294850
Autor:
Hazel Y. Stevens, Peter A. Kottke, Robert E. Guldberg, Mason A. Chilmonczyk, Andrei G. Fedorov
Publikováno v:
Biotechnology and Bioengineering. 116:121-131
Large-scale manufacturing of therapeutic cells requires bioreactor technologies with online feedback control enabled by monitoring of secreted biomolecular critical quality attributes (CQAs). Electrospray ionization mass spectrometry (ESI-MS) is a hi